Using transfer-matrix and stationary phase methods, we study the tunneling time (group delay time) in a ferromagnetic monolayer graphene superlattice. The system we peruse consists of a sequence of rectangular barriers and wells, which can be realized by putting a series of electronic gates on the top of ferromagnetic graphene. The magnetization in the two ferromagnetic layers is aligned parallel. We find out that the tunneling time for normal incident is independent of spin state of electron as well as the barrier height and electron Fermi energy while for the oblique incident angles the tunneling time depends on the spin state of electron and has an oscillatory behavior. Also the effect of barrier width on tunneling time is also investigated and shown that, for normal incident, the Hartman effect disappears in a ferromagnetic graphene superlattice but it appears for oblique incident angles when the x component of the electron wave vector in the barrier is imaginary
Based on transfer-matrix and stationary phase methods, we have investigated the tunneling time (group delay time) through monolayer graphene superlattice in the presence of Rashba spin-orbit interaction. It is found that the tunneling time has an oscillatory behavior with respect to Rashba spin-orbit interaction strength. Furthermore, the tunneling time for normal incident angle is independent of spin state of electron, while for oblique incident angles, it depends on the spin state of electron. It is also shown that, for normal incident, the Hartman effect vanishes, while for oblique incident, the Hartman effect appears whenever the x (the growth direction of superlattice) component of the electron wave vector inside the barriers is imaginary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.